Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Research
  • Acrosian debuts as AI-focused biometrics CRO

Acrosian debuts as AI-focused biometrics CRO

July 28, 2026Posted inResearch

The founders of contract research organization Quartesian have reunited to form Acrosian, a CRO designed to be purpose-built for the AI era.

Post navigation

Previous Post
Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
Next Post
Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3 trial

Recent Posts

  • Adipose triglyceride lipase driven lipolysis as a targetable metabolic vulnerability in prostate cancer with intrinsic metabolic inflexibility
  • ORNL launches national cement and concrete innovation hub
  • Mechanical strain creates chirality
  • Okafor named president-elect of ACVPM Epidemiology Specialty
  • Donor cord blood composition may influence CAR NK cell therapy outcomes

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top